Literature DB >> 22041302

Vaccination by delayed treatment of infection.

Sean P Stromberg1, Rustom Antia.   

Abstract

Two medical interventions allow us to combat infectious diseases: vaccination which can be administered well in advance of exposure, and antimicrobials which are most often administered contemporaneously with exposure. In this paper we show how they can, in principle, be combined - with infection followed by treatment being used as a form of vaccination. We use mathematical models to examine how appropriately administered antimicrobial treatment following natural infection can be used to reduce the pathology caused by the infection, and also generate long-lasting immunological memory to the pathogen. The models explore the tradeoff between reduction in pathology and strength of immunization. This tradeoff suggests a limited treatment window during which antimicrobial treatment can be started and provide both amelioration of disease symptoms and long-term immunity. This approach may be particularly well suited to combat the emergence of novel pandemic influenza infections particularly for individuals such as medical healthcare professionals at greatest risk for exposure during the initial stages of a pandemic.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22041302      PMCID: PMC3391078          DOI: 10.1016/j.vaccine.2011.10.047

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

1.  Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells.

Authors:  S M Kaech; R Ahmed
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

2.  Emergence of drug-resistant influenza virus: population dynamical considerations.

Authors:  Roland R Regoes; Sebastian Bonhoeffer
Journal:  Science       Date:  2006-04-21       Impact factor: 47.728

3.  Does programmed CTL proliferation optimize virus control?

Authors:  Dominik Wodarz; Allan Randrup Thomsen
Journal:  Trends Immunol       Date:  2005-06       Impact factor: 16.687

Review 4.  Immunization against diseases caused by Theileria parva: a review.

Authors:  G Uilenberg
Journal:  Trop Med Int Health       Date:  1999-09       Impact factor: 2.622

Review 5.  Drugs in development for influenza.

Authors:  David A Boltz; Jerry R Aldridge; Robert G Webster; Elena A Govorkova
Journal:  Drugs       Date:  2010-07-30       Impact factor: 9.546

6.  Vaccination alters the balance between protective immunity, exhaustion, escape, and death in chronic infections.

Authors:  Philip L F Johnson; Beth F Kochin; Megan S McAfee; Ingunn M Stromnes; Roland R Regoes; Rafi Ahmed; Joseph N Blattman; Rustom Antia
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

7.  Early programming of T cell populations responding to bacterial infection.

Authors:  R Mercado; S Vijh; S E Allen; K Kerksiek; I M Pilip; E G Pamer
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

8.  Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Anthony E Fiore; Alicia Fry; David Shay; Larisa Gubareva; Joseph S Bresee; Timothy M Uyeki
Journal:  MMWR Recomm Rep       Date:  2011-01-21

9.  Natural immunization against malaria: causal prophylaxis with antibiotics.

Authors:  Johannes Friesen; Olivier Silvie; Elyzana Dewi Putrianti; Julius C R Hafalla; Kai Matuschewski; Steffen Borrmann
Journal:  Sci Transl Med       Date:  2010-07-14       Impact factor: 17.956

10.  Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection.

Authors:  Andrej Kosmrlj; Elizabeth L Read; Ying Qi; Todd M Allen; Marcus Altfeld; Steven G Deeks; Florencia Pereyra; Mary Carrington; Bruce D Walker; Arup K Chakraborty
Journal:  Nature       Date:  2010-05-05       Impact factor: 49.962

View more
  3 in total

Review 1.  Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response.

Authors:  Veronika I Zarnitsyna; Juliano Ferrari Gianlupi; Amit Hagar; T J Sego; James A Glazier
Journal:  Curr Opin Virol       Date:  2021-08-24       Impact factor: 7.090

2.  Coevolutionary immune system dynamics driving pathogen speciation.

Authors:  Kimberly J Schlesinger; Sean P Stromberg; Jean M Carlson
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

3.  Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment.

Authors:  Erida Gjini; Patricia H Brito
Journal:  PLoS Comput Biol       Date:  2016-04-14       Impact factor: 4.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.